Minnesota Department of Health

The Minnesota e-Health Advisory Committee meeting focused on identifying potential action items and workgroups for the upcoming year, along with providing an update on the coordinated response to the Health Technology Ecosystem RFI. Key discussion areas included care coordination and care transitions, where emphasis was placed on communicating the 'why' for data exchange and identifying challenges in coordination delivery. Discussions also covered Artificial Intelligence (AI), with suggestions to narrow the scope to patient-focused tools, workforce shortages, and establishing state leadership through clear guardrails. Other topics included cybersecurity, with interest in reviewing and updating the Foundations in Privacy Toolkit, public health data modernization, particularly timely data access and barriers like the MN Health Records Act, and interoperability challenges, including system gaps between Epic and non-Epic users and the impact of the paid medical leave program. Potential workgroups were discussed for 'Care to Coordinate' (including interoperability gaps), AI (to be potentially split into use/governance and workforce/education subgroups), and public health data modernization.

This report outlines the Minnesota e-Health Initiative's 2019 progress in advancing health information technology and its goals. Key areas of focus include improving health information exchange (HIE) across the state through strategic planning and grants, addressing the opioid epidemic via e-prescribing, enhancing the Minnesota Department of Health's data strategy and interoperability, and applying administrative simplification models to clinical data. The initiative works to ensure that all Minnesotans benefit from information and technology that supports health equity and wellbeing.

The meeting commenced with the Commissioner's welcome, emphasizing the key role of e-health, telehealth, and interoperability, and outlining the Minnesota Department of Health's commitment to advancing data modernization. The committee's purpose, established under statute as a public/private collaborative, was reviewed, highlighting its vision to advance health equity through information and technology. Key historical achievements since 2004 were presented, focusing on EHR requirements, HIE framework development, and progress since 2020, including federal rulemaking responses and MDH data strategy expansion. A significant portion of the discussion focused on prioritizing future work regarding regulatory considerations, interoperability and data exchange (especially bridging Epic and non-Epic users via TEFCA and USCDI alignment), health equity (including SDOH data and social services referrals), Artificial Intelligence (AI) use, cybersecurity, and public health reporting. Committee members also submitted survey comments regarding pharmacy interoperability, the potential use of patient advocacy AI, and the need for a unified data infrastructure to ensure health information follows individuals across care settings.

This legislative report from the Psychedelic Medicine Task Force advises the Minnesota legislature on the legal, medical, and policy issues associated with the legalization of psychedelic medicine in the state, specifically MDMA, LSD, and psilocybin. The report recommends creating a state-regulated clinical program for the therapeutic administration of psilocybin-containing mushrooms, removing criminal penalties for the personal use and possession of psilocybin-containing mushrooms, and allocating funding for further research into MDMA, psilocybin, and LSD. The task force envisions an incremental and flexible implementation approach, adapting to evolving scientific, medical, and legal developments while prioritizing cost, access, and equity.

The meeting agenda included administrative items such as task force logistical business and the approval of the August meeting summary. Key discussion points focused on decision preparation, task force report development updates, and voting on recommendations.